Clinical Trial Update: Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of autologous stem cell transplantation followed by a dendritic cell vaccine targeting p53 in patients with limited-stage small cell lung cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Autologous Stem Cell Transplant
• Dendritic cell vaccine targeting p53 (p53-targeted dendritic cell vaccine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-06-21